UnityPoint Health CEO Clay Holderman said his health system made a mistake when it used to leave decision making concerning new technology adoption up to the director of its venture fund instead of involving its frontline clinicians. UnityPoint’s clinicians didn’t take too well to this, so the health system re-structured its technology adoption process to prioritize the voices of its clinical staff.
In our first in-person event in two years, the MedCity INVEST conference March 28-30 at the Ritz Carlton Hotel in Chicago, there will be many opportunities to connect with startups, investors and potential collaboration partners.
MedCity News
More healthcare startups go public through SPACs but will they succeed?
More healthcare startups are choosing to go public through mergers with special-purpose acquisition companies publicly-traded shell companies created with the purpose of taking a private company public. But as the number of SPACs searching for targets increases, will the SPAC bubble burst?
Shares1
From the beginning, Hims & Hers CEO Andrew Dudum had imagined he would take his startup public through a traditional IPO. But last month, the direct-to-consumer health startup ended up taking a different route.
The startup merged with a special-purpose acquisition company formed by Oaktree Capital Management, effectively a shell company that goes public with the purpose of finding and acquiring a target company. The deal netted Hims & Hers a $1.6 billion valuation and $330 million in cash.